Mitchell Sinkler & Starr’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-465
Closed -$220K 158
2026
Q1
$220K Sell
465
-10
-2% -$5.03K 0.1% 140
2025
Q4
$222K Sell
475
-10
-2% -$4.64K 0.1% 135
2025
Q3
$207K Sell
485
-75
-13% -$29.1K 0.09% 141
2025
Q2
$215K Buy
+560
New +$202K 0.1% 137
2024
Q4
Sell
-660
Closed -$268K 194
2024
Q3
$268K Hold
660
0.07% 144
2024
Q2
$212K Buy
+660
New +$214K 0.05% 146

Other funds holding HCA

Mitchell Sinkler & Starr's HCA Position: Q2 2026 in Review

Mitchell Sinkler & Starr sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 465 shares — an estimated $220K sold.

Mitchell Sinkler & Starr first reported a position in HCA in Q2 2024 and held it in 6 quarters. The position peaked at $268K in Q3 2024. 337 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Mitchell Sinkler & Starr reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Mitchell Sinkler & Starr sold 465 HCA Healthcare shares in Q2 2026, an estimated $220K.
  • Mitchell Sinkler & Starr first reported a position in HCA Healthcare in Q2 2024 and held it in 6 quarters.
  • Mitchell Sinkler & Starr's HCA Healthcare position peaked at $268K in Q3 2024.
  • 337 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.